UPDATE 1-Fresenius reports solid Q3 thanks to emerging markets, home dialysis

German healthcare group Fresenius slightly exceeded third-quarter revenue forecasts on Tuesday, citing strong performance of its infusion drugs unit in emerging markets and growth in home treatment at its separately-listed dialysis business.